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School of Physics, University of Sydney, NSW 2006, AustraliaABSTRACT The uptake of glutamate in nerve synapses is carried out by the excitatory amino acid transporters (EAATs),
involving the cotransport of a proton and three Naþ ions and the countertransport of a Kþ ion. In this study, we use an
EAAT3 homology model to calculate the pKa of several titratable residues around the glutamate binding site to locate the proton
carrier site involved in the translocation of the substrate. After identifying E374 as the main candidate for carrying the proton, we
calculate the protonation state of this residue in different conformations of EAAT3 and with different ligands bound. We find that
E374 is protonated in the fully bound state, but removing the Na2 ion and the substrate reduces the pKa of this residue and favors
the release of the proton to solution. Removing the remaining Naþ ions again favors the protonation of E374 in both the outward-
and inward-facing states, hence the proton is not released in the empty transporter. By calculating the pKa of E374 with a K
þ ion
bound in three possible sites, we show that binding of the Kþ ion is necessary for the release of the proton in the inward-facing
state. This suggests a mechanism in which a Kþ ion replaces one of the ligands bound to the transporter, which may explain the
faster transport rates of the EAATs compared to its archaeal homologs.INTRODUCTIONExcitatory amino acid transporters (EAATs) are essential
for proper functioning of the nervous system because they
clear the excess glutamate released at the nerve synapses.
Glutamate can be toxic to neurons in large concentrations,
so problems in these transporters have been implicated in
many pathological conditions including cerebral ischemia,
amyotrophic lateral sclerosis, and Alzheimer’s disease (1).
EAATs transport the substrate across the membrane by
coupling to three Naþ ions and a proton, and a Kþ ion is
countertransported at every cycle. There is a great amount
of experimental data on EAATs, mostly through mutagen-
esis experiments (4–26), but also via structural information
(27,28) and the pH dependence of transport (19,29). A sig-
nificant step in our understanding of the EAATs came with
the solution of the crystal structures of the archaeal homolog
GltPh both in the outward- and inward-facing conformations
(30–32). GltPh has aspartate as the main substrate and the
transport mechanism is not coupled to a proton or Kþ, but
it still involves the cotransport of three Naþ ions. Only
two of them could be resolved in the crystal structure, but
radio-labeled Naþ experiments showed that three Naþ
ions were coupled to the substrate transport (33). The third
Naþ site (Na3) was determined from molecular dynamics
(MD) simulations, and mutagenesis experiments confirmed
that this site was present in GltPh and conserved in the EAAT
family (6). In GltPh two Na
þ ions bind before the substrate,
called Na1 and Na3, and the last Naþ ion (Na2) binds after
the substrate and the closure of the HP2 gate that forms
the binding site (53). Experimental studies show that thisSubmitted March 10, 2014, and accepted for publication May 5, 2014.
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0006-3495/14/06/2675/9 $2.00binding sequence is probably conserved in EAAT3, with
the binding of two Naþ ions in the absence of glutamate
and the third Naþ ion after the substrate (11,14).
Recently, we have created homology models for the
outward- and inward-facing states of EAAT3 based on the
GltPh structures in the same conformations. GltPh shares
~37% sequence identity with the EAATs, but the homology
is much higher for residues near the binding pocket, reach-
ing around 60% in this region. Furthermore, almost all of the
residues shown to be involved in the binding of Naþ ions
and the substrate in GltPh are conserved in the EAATs
(23,30–32,34,35). We have shown that the model is stable
with glutamate as a ligand, and that the coordination of
the ligands can be reproduced in good agreement with muta-
genesis experiments (36). A major result from this work is
that the substrate is not stably bound unless the E374 side
chain of EAAT3 is protonated, making this residue a natural
candidate for the proton carrier, which also agrees well with
experiments (19). Using the inward-facing state of EAAT3
from our model, we have also investigated three possible
binding sites for the Kþ ion, and found a high-affinity site
that overlaps with the Na1 and Na3 binding sites.
Even though there is strong theoretical and experimental
evidence pointing to the residue E374 as the proton carrier,
the mechanism of proton association and dissociation from
this residue in the outward and inward states of EAAT3
remains unknown. Furthermore, the protonation states of
other titratable residues close to the binding site has not
been thoroughly investigated, and in MD simulations, it is
usually assumed that they retain the same protonation states
as in solution. Here, we use homology models of EAAT3 to
address these issues. We perform free energy perturbation
(FEP) calculations to obtain the pKa values of different
residues close to the substrate binding site in the fully boundhttp://dx.doi.org/10.1016/j.bpj.2014.05.010
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the only one being protonated under these conditions, we
calculate the pKa value of this residue in different states of
the transporter and with different ligands bound. We show
that the protonation/deprotonation of E374 is coupled to
the binding/unbinding of the substrate, as well as the
closure/opening of the HP1 and HP2 gates that give the
substrate access to the solution. We also show that the bind-
ing of a Kþ ion in the inward state of EAAT3 is necessary
for the deprotonation of E374, so that only the Kþ ion is
transported back to the extracellular media in the second
half of the transport cycle.FIGURE 1 The thermodynamic cycle used in the FEP/TI calculations: A
represents the side chain of interest,H is the proton, the indices p and d refer
to the protonated and deprotonated states, and the subscripts m and pr
indicate that A is in the bulk solvent (model compound) and in the protein,
respectively.METHODS
Model system and simulation details
For the outward- and inward-facing conformations of EAAT3 we used the
same models created in our previous work (36), built from their respective
GltPh templates (Protein Data Bank (PDB) IDs 2NWX and 3KBC, respec-
tively) and equilibrated in the presence and absence of the various ligands in
both states. The GltPh templates have the substrate binding site occluded
from the solvent, with an aspartate and two Naþ ions bound (Na1 and
Na2). To build the models, we have used the program MODELLER (37)
and the alignment from (30). The templates had Asp, Na1, Na2, and Na3
bound, with the last Naþ added at the binding site as described in (6).
We have created the models including the ligands to obtain EAAT3 struc-
tures in the fully bound states. EAAT3 has a sequence of around 50 residues
close to the trimerization domain, called the 4B-4C loop, which is not pre-
sent in GltPh. To ensure the robustness of the EAAT3 trimers, we had to
exclude this region from the models. Experiments have shown that cysteine
substitution in the residues from this loop has little effect on the transporter
properties (27). To make sure that the truncation of this segment has little
effect on our results, we have also built outward and inward models
including the 4B-4C loop (36). We have shown that this region is not close
to the conformational changes we investigated in this study or to the bound
ligands, which corroborates our approach (36). We have created 20 models
for each conformation and assessed the quality of the structures using the
Swiss Model Server (38,39). After choosing the best models, we have con-
structed a trimer for each conformation by superposing the EAAT3 mono-
mer to chains A, B, and C of GltPh. In addition to these two models, we have
also created a new model for the outward-apo state of EAAT3 from a recent
crystal structure of GltTk (PDB ID: 4KY0), another archaeal homolog of the
EAATs and a close homolog of GltPh (40). The GltTk structure is in the
outward-apo state with the HP2 gate open, for which there were no crystal
structures of EAAT3 homologs available until recently. We built this model
following the same protocol used for GltPh and also used the same tools to
assess the quality of the structures.
The simulation systems for the models built from the GltPh templates
were prepared and equilibrated as described in (36). The EAAT3 system
built from the GltTk template is prepared in the same way, using the soft-
ware VMD (41). First the EAAT3 trimer in the apo-state is embedded in
a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) phospholipid
bilayer. We then solvate the protein-membrane complex in a box of water
molecules with 54 Naþ ions and 45 Cl ions. The extra Naþ ions are
included to keep the system neutral. The simulation box has 237 lipid
molecules and 15,851 water molecules, with a total of 98,124 atoms. The
system is then equilibrated in two stages. First, the coordinates of the ligand
and protein atoms are fixed and the system is equilibrated with 1 atm
pressure coupling in all directions until the correct water and lipid densities
are obtained. At this point, the x- and y-dimensions of the simulation box
are fixed, and pressure coupling is applied only in the z direction (typical
dimensions of the simulation are 113 113 74 A˚3). In the second stage,Biophysical Journal 106(12) 2675–2683the protein is gradually relaxed by reducing the restraints in several steps
during MD simulations lasting 2.4 ns. We then perform a further 15 ns of
simulations with no restraints applied.
MD simulations are performed using the NAMD program (42) with the
CHARMM36 force field (43). The temperature is maintained at 300 K
using Langevin damping with a coefficient of 5 ps1, and the pressure is
kept at 1 atm using the Langevin piston method with a damping coefficient
of 20 ps1 (44). Periodic boundary conditions with the particle mesh Ewald
method are employed to calculate the electrostatic interactions without
truncation. The Lennard-Jones interactions are switched off between
10 and 12 A˚ using a smooth switching function. A time step of 2 fs is
used in all MD simulations.Free energy calculations
To calculate the pKa values of the aspartate and glutamate side chains in the
vicinity of the glutamate binding site, we use the alchemical FEP and
thermodynamic integration (TI) methods in MD simulations (45). These
methods use an explicit solvent and have advantages over continuum
electrostatic models. Continuum models are very sensitive to the dielectric
constant assigned to the protein interior, and the value used is usually an
empirical parameter with a value ranging from 8 to 20 to account for
different effects such as water penetration, protein flexibility, and confor-
mational rearrangements in response to the ionization state (46–48). These
models are also influenced by the method used in constructing the dielectric
boundary between the protein and the surrounding environment (49). All
these effects can be taken into account rigorously by computing the free
energy difference between the protonated and deprotonated forms using
the MD/FEP method with an explicit solvent (50). This is carried out by
alchemically transforming a deprotonated carboxyl group to a protonated
one in the protein while simultaneously performing the opposite trans-
formation in a reference residue located in bulk solvent, according to the
thermodynamic cycle shown in Fig. 1. The reference residues, or model
compounds, that we use are N-acetyl-L-isoasparagine for the aspartate
calculations and the N-acetyl-L-isoglutamine for the glutamate calculations
(Fig. 2). These two compounds reproduce the side chains of aspartate and
glutamate and also the backbone atoms, but do not have the zwitterion
charges that could affect the electrostatic component of the results. The
experimental pKa values of N-acetyl-L-isoasparagine and N-acetyl-L-
isoglutamine are 4.0 and 4.3, which compare well with the pKa values of
aspartate (3.7) and glutamate (4.3) (51). The CHARMM parameters are
readily available for these compounds, which further facilitate their use
in FEP calculations. The pKa value of a residue in a protein is given by (52):
pKa ¼ pKaðmodelÞ  DDGpr
2:3kBT
; (1)
where DDGpr can be calculated from the thermodynamic cycle in Fig. 1
FIGURE 2 The model compounds used in our free energy calculations in
bulk. (A) N-acetyl-L-isoasparagine is used for aspartate, (B) N-acetyl-L-
isoglutamine is used for glutamate. To see this figure in color, go online.
TABLE 1 Comparison of the QMEAN scores and DFIRE
energies between the GltTk crystal structure and the EAAT3
homology model
Structure QMEAN score DFIRE Energy
GltTk (4KY0) 0.515 679:6
EAAT3 (outward apo) 0.484 608:3
The QMEAN score goes from 0 to 1, 1 being the best possible model.
Lower DFIRE energy values indicate better quality structures.
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¼ DGprðd/pÞ  DGmðd/pÞ: (2)
MD/FEP calculations are performed to determine the free energy difference
on the right side of Eq. 2, corresponding to the horizontal legs in Fig. 1.
We use both the MD/FEP and MD/TI methods to calculate DDGpr by
alchemically transforming a deprotonated glutamate residue to a protonated
one in the protein, whereas doing the opposite transformation in the model
compound in bulk. This process is carried out as a function of the reaction
coordinate l, in which the end points are at l ¼ 0 and l ¼ 1. In the FEP
method, the interval between l ¼ 0 and 1 is divided into n subintervals
with fli; i ¼ 1;.; n 1g, and for each subinterval the free energy
difference is calculated from the ensemble average
DGi ¼ kBT lnhexp½  ðHðliþ1Þ  HðliÞÞ=kBTili ; (3)
where HðlÞ ¼ ð1 lÞH0 þ lH1, with H0 and H1 representing the states
with the proton in the model compound and in the protein residue, respec-
tively. The free energy difference is obtained from the sum,
DDGpr ¼
P
iDGi. In the TI method, the ensemble average of the derivative,
vHðlÞ=vl, is obtained at several l values, and the free energy difference is
calculated from the integral:
DDGpr ¼
Z 1
0

vHðlÞ
vl

l
dl: (4)
Provided the integrand can be fitted well with a polynomial, Gaussian quad-
rature provides an efficient and accurate method for evaluation of such
integrals because it allows for longer sampling of a smaller number of
windows. In the FEP simulations we use 66 exponentially spaced windows
with 40 ps of equilibration plus 40 ps of production for each window. In the
TI method, we use seven windows starting from the nearest FEP windows,
and run 0.4 ns of equilibration plus 0.8 ns of data collection for each
window. These parameters have been found to be optimal in previous
studies of GltPh (53,54). We report here only the TI results because they
show better convergence, but we always check for consistency betweenthe two methods, as well as performing both the forward and backward
transformations in each case to check against any hysteresis effects. It is
important to assess the convergence of pKa calculations and determine
the associated uncertainty (55). Evidence for the convergence of the TI re-
sults and the consistency between the TI and FEP results are presented in
Fig. S1 in the SupportingMaterial. The statistical errors shown in the results
are obtained by performing block data analysis over 100 ps blocks.RESULTS AND DISCUSSION
Evaluating the model
We have assessed the quality the open-state EAAT3 model
obtained from GltTk using three different methods, similar
to the case of the EAAT3 models obtained from the closed
states of GltPh (36). QMEAN (Qualitative Model Energy
ANalysis) is a composite scoring function ranging from
0 to 1, which describes the major geometrical aspects of
protein structures (39). DFIRE (Distance-scaled, Finite
Ideal-gas REference) is a potential based on a database of
nonhomologous proteins (38). DOPE (Discrete Optimized
Protein Energy) is an atomic distance-dependent statistical
potential calculated from a sample of native structures
(37). The first two are available on the Swiss Model Server,
and the last one is built into the program MODELER. The
scores obtained for the EAAT3 models based on the GltPh
templates can be found in (36). In Table 1 we show the
QMEAN scores and DFIRE energies for the original GltTk
crystal structure, as well as our EAAT3model in the outward
apo state. As in the case of GltPh (36), the QMEAN scores
and DFIRE energies are very similar, as well as the energy
profiles obtained using DOPE (Fig. 3). This indicates that,
even though the homology is not high between the archaeal
and the human transporters, we can still build high quality
models using the former as a template. Furthermore, we
are looking at ligand binding and small conformational
changes instead of large conformational transitions. There-
fore, the models built for the EAATs in the vicinity of the
outward- and inward-facing states are likely to retain the
same features of the archaeal transporters in the same states.pKa values in the glutamate-bound outward
EAAT3
The first step in identifying the proton carrier is to calculate
the pKa values of all titratable residues in the vicinity of the
binding pocket. The fully bound outward closed stateBiophysical Journal 106(12) 2675–2683
FIGURE 3 DOPE per-residue score for the 4KY0 crystal structure
(black) and our EAAT3 model in the apo outward-facing state (red). The
residues are numbered according to the GltTk sequence. To see this figure
in color, go online.
FIGURE 4 (A) The substrate binding site in the outward-facing fully
bound state, showing the bound glutamate (in green) and the titratable res-
idues in this region. (B) The binding sites of the Na1 and Na3 ions in the
same state of EAAT3, coordinated by the D455 and D368 side chains,
respectively. To see this figure in color, go online.
2678 Heinzelmann and Kuyucakprecedes the transition to the inward-facing transporter, and
therefore should have a proton bound. We show this struc-
ture with all ligands bound in Fig. S2 A. We choose this
equilibrated model to look for the proton carrier in the
EAATs, by performing pKa calculations as described in
Methods. We have shown previously that the substrate is
not stable unless the E374 residue—which is a glutamine
in GltPh and GltTk—is protonated (36). We cannot discard
the possibility that other residues in the binding pocket
could also be protonated, therefore, in addition to E374,
we have also calculated the pKa values of the residues
D368, D440, D444, and D455. The side chains of D455
and D368 are involved in Naþ binding at sites Na1 and
Na3, the side chain of D444 coordinates the substrate
a-amino group, and the side chain of D440 makes a salt
bridge with the R447 residue (Fig. 4). This arginine also co-
ordinates the glutamate substrate side-chain carboxyl group.
To test the suitability of our reference residues in bulk, we
have also calculated the pKa values of an aspartate (D83)
and a glutamate (E135) residue in the protein that are fully
exposed to the solvent and are not close to any charged
groups. These residues are expected to retain the same
pKa values as in bulk. To avoid the unbinding of ligands dur-
ing the protonation process, all the ligands are restrained
during the pKa calculations at the binding sites found in
(36). The harmonic restraints are applied on all the heavy
atoms of the substrate, with a spring constant of k ¼ 0.5
(kcal/mol)/A˚2 on each. Similarly, the ions are restrained
with a spring constant of k ¼ 5 (kcal/mol)/A˚2. These values
allow fluctuations of the ligands around their average posi-
tions ðr0Þ, similar to the ones observed for the unrestrained
ligands obtained from k  3kBT=hðr r0Þ2i, but do not
allow the ligand to leave the binding site (56). This proce-
dure enables us to calculate the pKa values in a given state,
so we can determine which residues are protonated underBiophysical Journal 106(12) 2675–2683these conditions. The Na1 and Na2 ions share the same
binding sites as the GltPh 2NWX crystal structure, and the
Na3 site binding site was determined from MD simulations
and mutagenesis experiments (6). The coordination of the
glutamate substrate is very similar to that of aspartate
in GltPh, which is stable with a protonated E374, and is
in good agreement with the mutagenesis experiments
(21,23,36).
In Table 2, we present the calculated pKa values of the
glutamate and aspartate residues mentioned previously.
The positions of the titratable residues relative to the bound
ligands, with their calculated pKa values, are shown in
Fig. S2 B. The pKa values for the test residues D83 and
E135 are 3.5 and 4.2, respectively, which are in good agree-
ment with the experimentally determined pKa values for the
side chains of aspartate and glutamate (3.7 and 4.3). Thus,
our models can accurately reproduce the properties of the
aspartate and glutamate side chains in bulk water. Returning
to the EAAT3 residues, we find a pKa value of 19.1 for E374
(Table 2), indicating that this residue is undoubtedly proton-
ated in the fully bound outward state of EAAT3. We believe
that this large pKa value is related to both the presence of the
glutamate substrate and the closure of the HP2 gate after this
ligand binds. We have shown previously that glutamate
TABLE 2 Calculated pKa values of various aspartate and
glutamate residues in EAAT3
Residue DDGforpr DDGbackpr DDGpr DpKa pKa
D83 0:450:8 1:150:9 0:750:8 0:550:6 3:550:6
E135 0:250:9 0:250:8 0:250:8 0:150:6 4:250:6
E374 20:150:7 20:351:1 20:250:9 14:750:7 19:150:7
D368 18:850:9 17:050:9 17:950:9 13:150:7 9:150:7
D440 6:851:7 6:051:1 6:451:4 4:751:0 0:751:0
D444 0:450:9 0:851:1 0:251:0 0:150:7 3:950:7
D455 16:352:3 14:951:5 15:651:9 11:451:4 7:451:4
The forward and the backward calculations of the protonation free energies
are listed in the second and third columns, respectively, and their average in
the fourth column. The shift DpKa is given in the fifth column, and the final
value of the pKa is given in the last column. Errors are estimated from block
data analysis using 100 ps windows. All free energies are in kcal/mol.
FIGURE 5 (A) The region around E374 (purple) in the fully bound state,
where this residue is buried under a series of hydrophobic residues from the
HP2 and TM7 segments. (B) After the removal of the substrate and the Na2
ion, the HP2 gate opens and the E374 side chain is hydrated. To see this
figure in color, go online.
MD Simulations of Proton Transport in EAAT3 2679substrate is not stable in the binding site if E374 is deproto-
nated due to the repulsion between the negatively charged
carboxyl groups (36). Therefore, protonation of E374 would
be energetically favorable in the presence of the sub-
strate. Furthermore, E374 is isolated from the solvent by a
nonpolar region formed by a series of hydrophobic residues
at the TM7 (M367 and T370) and HP2 (A404, A408, A414,
T418, and V422) segments (Fig. 5 A). All of them are
strictly conserved throughout the EAAT family except for
V422, which is an isoleucine in EAAT2. Conservation of
this hydrophobic motif in all EAATs is indicative of its func-
tional importance in stabilizing the protonated state of E374.
Experimental studies on the ASCT1 transporter (57) show
that pH sensitivity can be engineered into it by mutating
the residue Q386 (equivalent to E374 in EAAT3) to gluta-
mate. It is also found that T382 (equivalent to T370 in
EAAT3) helps in stabilizing the proton bound to the E386
residue in ASCT1[Q386E], which is consistent with the
results presented here. Further mutations in the hydrophobic
region mentioned previously may similarly demonstrate the
role of the surrounding TM7 and HP2 residues in the proton-
ation of E374.
The experimental pKa value of the proton carrier in
EAAT3 is ~8 (29). This value is determined from the pH-
dependence of the uncoupled and coupled currents associ-
ated with glutamate transport, thus reflecting the free energy
difference between the fully bound protonated state and the
ensemble of deprotonated conformations where the substrate
translocation cannot happen. We believe that the deproto-
nated state of E374 is likely to be solvent exposed and
without a bound substrate, given that the substrate is unstable
under these conditions. Because accounting for the confor-
mational changes and the unbinding of the substrate is not
feasible in our FEP calculations, we have calculated the
pKa for the fully bound closed state, where the E374 side
chain is isolated from the solvent and glutamate is bound.
Hence, the calculated pKa value of 19.1 cannot be directly
compared to the experimental value, but it is sufficient to
ascertain that E374 is protonated in the fully bound trans-
porter. After 60 ns of MD simulations of EAAT3 in theabsence of the substrate and the Na2 ion (36), we have
observed opening of the HP2 gate and hydration of E374
(Fig. 5 B). To quantify the change in hydration of E374, we
have calculated the radial distribution function of the water
molecules around the carboxyl oxygens of E374 in the fully
bound, closed, and substrate-free, open states (Fig. S3). The
dramatic increase in hydration of E374 in the absence of the
substrate is expected to lower the pKa value of E374, which
may trigger release of the proton in the inward state. This
scenario will be explored further in the next section.
We next consider the pKa values of other titratable resi-
dues. The side chains of D368 and D455, which coordinate
Na3 and Na1, respectively, give very large values of DDGpr,
and consequently very low pKa values. This is a direct
consequence of the proximity of these two side chains to
Na1 and Na3 and the absence of water molecules in thisBiophysical Journal 106(12) 2675–2683
2680 Heinzelmann and Kuyucakregion—there is only one water molecule in the binding
sites of Na1, Na3 and the substrate (Fig. 4). Protonating a
negatively charged aspartate side chain that coordinates a
positively charged Naþ ion results in a very high energetic
penalty, which is reflected in the calculated pKa values.
This indicates that the residues D368 and D455 have to
be deprotonated to coordinate the Na1 and Na3 ions.
We have shown previously that Na1 leaves the binding
site shortly after D455 is protonated (36), which is consis-
tent with the results obtained here. The D440 and D444
residues also give low pKa values, most likely because
they are also involved in charge interactions with the
R447 side chain and the substrate a-amino group, respec-
tively (Fig. 4 A).pKa values of E374 in different states of EAAT3
In our previous study of EAAT3 (36), we obtained a series
of states by running simulations with different combinations
of bound ligands. In addition to the fully bound states in the
outward- and inward-facing conformations, we also simu-
lated these two conformations in the apo state and with
only Na1 and Na3 bound to the transporter. Furthermore,
we investigated the binding sites of the Kþ ion in the inward
model of EAAT3 and calculated the binding free energies of
the Kþ ion in three sites suggested by the mutagenesis ex-
periments (36). Here, we calculate the pKa value of E374
in all these states, as well as in the EAAT3 model built
from the apo GltTk (Table 3). Our aim is to gain insights
into the mechanism of proton binding and release and how
that relates to the binding/unbinding of the other ligands.
Because all our results are obtained using the EAAT3 modelTABLE 3 Calculated pKa values of E374 with different ligands
bound to the outward and inward states of EAAT3
Outward EAAT3
Ligands DDGforpr DDGbackpr DDGpr DpKa pKa
apo 10:451:0 10:150:9 10:251:0 7:450:7 11:750:7
apo (GltTk) 9:251:5 11:551:2 10:351:4 7:551:0 11:851:0
Na1, Na3 4:050:9 2:151:1 3:051:0 2:250:7 6:650:7
Na1, Na3,
Glua
8:950:9 7:751:4 8:351:2 6:150:9 10:450:9
fully bound 20:150:7 20:351:1 20:250:9 14:750:7 19:150:7
Inward EAAT3
Ligands DDGforpr DDGbackpr DDGpr DpKa pKa
apo 10:251:6 10:151:2 10:251:4 7:451:0 11:751:0
Na1, Na3 3:351:5 3:451:2 3:351:4 2:451:0 6:751:0
fully bound 22:751:1 22:250:9 22:451:0 16:350:7 20:650:7
K-site 1 0:651:0 0:551:1 0:551:0 0:450:7 4:750:7
K-site 3 4:051:0 3:351:4 3:651:2 2:650:9 6:950:9
The forward and the backward calculations of the protonation free energies
are listed in the second and third columns, respectively, and their average in
the fourth column. The shift DpKa is given in the fifth column, and the final
value of the pKa is given in the last column. Errors are estimated from block
data analysis using 100 ps windows. All free energies are in kcal/mol.
aWith the HP2 gate open and the hydrated E374 side-chain.
Biophysical Journal 106(12) 2675–2683created from the fully boundGltPh, it is important to check its
consistency by comparing the apo state result with that ob-
tained from the EAAT3 model based on the apo GltTk tem-
plate. As seen from the top two rows in Table 3, there is
excellent agreement between the two results, confirming
the relevance of the apo-state EAAT3 model used in the cal-
culations. Comparison of the pKa values between the out-
ward and inward states for the apo, Na1-Na3 bound, and
fully bound states (Table 3) shows that they are very similar.
Even though this symmetry shows the consistency of our re-
sults, experiments based on the pH dependence of the for-
ward and reverse transport modes reveal an asymmetry of
1.5 pKa units between the outward- and inward-facing states
of EAAT3 in the presence of the substrate (29). This discrep-
ancymight arise from the free energies involved in the gating
process of the substrate-bound EAAT3, which we do not
consider in this study. This step isolates E374 from the sol-
vent, directly affecting its pKa, and is likely to be different
in the inward and outward states, as shown in the metady-
namics studies of gate opening in GltPh (58).
We see from Table 3 that absence of the substrate and the
Na2 ion (Na1, Na3 rows) has a great effect on the pKa of this
residue, which can be traced to hydration of E374 and the
absence of the negatively charged substrate (Fig. 5). The
pKa value is reduced to 6.6 and 6.7 for the outward- and
inward-states, meaning that around 85% of the E374 side
chains are deprotonated when only Na1 and Na3 are bound.
This shows that the binding of the substrate and the closure
of the HP2 gate in the presence of the these two Naþ ions
strongly favor proton binding to E374. To determine the
relative contribution of these two processes, we have
removed the Na2 ion from the fully bound outward state
and simulated the system with a deprotonated E374 and a
restrained substrate for 50 ns. In one of the chains of the
transporter, we obtain a state in which Na1, Na3, and gluta-
mate are bound, but the HP2 gate is fully open and E374 is
hydrated. The pKa value of E374 under these conditions is
10.4 (Table 3), which indicates that binding of glutamate
is sufficient for the protonation of E374, and the closure
of the gate further stabilizes it. As in GltPh, Na1 and Na3
are necessary for substrate binding to EAAT3, but these
ions also favor the deprotonation of E374 and the conse-
quent instability of the substrate in the binding site. On
the other hand, the system with glutamate bound and a pro-
tonated E374 is very stable, and also produces a high value
for the pKa of this residue. Therefore, we propose that pro-
ton and substrate binding are mutually coupled, that is, sub-
strate binding brings about the protonation of E374 and vice
versa. This mechanism is corroborated by experiments,
which show that in the pH range from 6 to 10, saturation
of glutamate binding can be achieved by either increasing
the glutamate concentration or decreasing the pH in the
extracellular media (29). An interesting observation is that
the pKa value is 11.7 for both apo states, indicating a proton-
ated E374 residue. We attribute this to the negative potential
MD Simulations of Proton Transport in EAAT3 2681induced by the negative charges of the D368 and the D455
residues, which are 10 and 15 A˚ away from E374, respec-
tively. Even though there are water molecules between these
residues and E374, they are mostly limited to the surface of
the protein, and hence provide a limited dielectric screening
compared to bulk water (Fig. 6 A). Presence of the Na1 and
Na3 ions neutralizes these negative charges, thereby
explaining the reduction in the pKa value of E374 when
the Na1 and Na3 ions are bound.FIGURE 6 (A) The region between E374 (purple) and the D368 and
D455 side chains, which has water molecules located mostly on the surface
of the protein, resulting in reduced dielectric screening. (B) The same area
but now in the presence of the bound Kþ at site 1. We see that, in addition
to the presence of the positively charged Kþ ion, the side chain of D368 is
also hydrated. (C) The substrate binding site with a Kþ ion bound at site 3,
which now has a positive charge instead of the negatively charged substrate,
reducing the pKa of E374. To see this figure in color, go online.We next look at the release of the proton into the intracel-
lular media, and how this is related to Kþ binding. Similar to
the outward state, this proton is released when we remove
the substrate and the Na2 ion, but it is bound if the trans-
porter is empty because the pKa of E374 is 11.7 in the in-
ward-apo state (Table 3). To investigate the influence of
Kþ binding on the proton release, we have also calculated
the protonation state of E374 in the presence of Kþ in
each of the three sites considered in our previous study
(36). For Kþ site number 2, which is coordinated by the
same E374 side chain, Kþ is not stable in the binding site
and leaves it shortly after the protonation of this residue
(not shown). Therefore, the deprotonation of E374 is abso-
lutely necessary for Kþ binding at this site. In the case of Kþ
sites 1 and 3, we obtain pKa ¼ 4.7 when Kþ is bound in site
1 and pKa¼ 6.9 when Kþ is bound in site 3 (Table 3). This is
a direct consequence of introduction of a Kþ ion in the apo
state, which either replaces the Na1 and Na3 sodium ions
(site 1) or the substrate a-amino group (site 3). Interestingly,
introduction of one Kþ ion at site 1 causes a larger shift in
the pKa value compared to the apo state than the presence
of both Na1 and Na3 (4.7 vs. 6.7). This can be explained
because the binding of Kþ at site 1 not only reduces the
negative potential in that region, but it also helps to hydrate
the D368 side chain, which does not happen in the apo trans-
porter (Fig. 6, A and B). In the case of site 3, the D444 side
chain is part of the substrate binding site (coordinates its
a-amino group), and is separated from E374 by the salt
bridge between R447 and D440 (Fig. 6 C). The presence
of a positive charge in this region, instead of the negatively
charged substrate or an empty binding site, is responsible for
reducing the pKa value of E374, deprotonating this residue
when Kþ is bound at site 3. These results show that binding
of a Kþ ion is necessary for the deprotonation of the E374
side chain and the completion of the transport cycle.CONCLUSIONS
In conclusion, we have performed rigorous pKa calculations
using the MD/FEP method to identify protonated residues
in the human glutamate transporter EAAT3, and also to
elucidate the mechanism of proton transport. Our calcula-
tions show that E374 is the only protonated residue in the
fully bound outward-facing state, which agrees with exper-
iments that point to this residue as the proton carrier in
EAATs. We find that both the presence of the substrate
and the closure of the HP2 gate contribute to the high pKa
value obtained in our calculations. A hydrophobic region
formed by conserved residues in the TM7 and HP2 seg-
ments isolates E374 from the solvent, favoring the presence
of a neutral side chain as opposed to a negatively charged
one. When we remove the substrate and the Na2 ion,
we see the opening of the HP2 gate and the hydration of
the E374 side chain, which now has a pKa value below
the physiological pH and therefore should be mostlyBiophysical Journal 106(12) 2675–2683
2682 Heinzelmann and Kuyucakdeprotonated. If we remove the remaining Naþ ions, the
negative charges from the D368 and D455 side chains
induce the protonation of E374, which now has a pKa of
 12. There is good agreement between the results from
the apo states created from the fully bound GltPh and the
apo GltTk templates, confirming the relevance of the former
in apo state calculations.
To understand the mechanism of proton release, we
perform the pKa calculations in the inward-facing state of
EAAT3 in the fully bound state, with only Na1 and Na3
bound, in the apo state, and also with Kþ bound in three
possible sites previously determined. There is good symme-
try between the values in the inward and the outward confor-
mations of EAAT3, with the inward apo state also having a
protonated E374 carboxyl group. This result shows that the
release of all the ligands and the hydration of E374 is not
enough to deprotonate this residue, and therefore the proton
release should depend on Kþ binding to the inward trans-
porter. Indeed, the binding of the Kþ ion in any of the sites
tested induces the deprotonation of E374, by either reducing
its pKa or directly coordinating this ion. This is consistent
with a mechanism in which the Kþ ion replaces either the
Na1 and Na3 ions, the substrate, or the proton itself, so
the transporter never needs to reach the inward apo state.
This is in contrast to GltPh, in which all the ligands have
to unbind for the relocation of the transporter to the outward
state. This difference might explain the much faster
transport rates of the human transporters compared to the
archaeal ones, and also the need for the countertransport
of a Kþ ion in the EAATs.SUPPORTING MATERIAL
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